Literature DB >> 16331432

Secular changes in health care utilization and work absence for migraine and tension-type headache: a population based study.

A C Lyngberg1, B K Rasmussen, T Jørgensen, R Jensen.   

Abstract

OBJECTIVE: To assess changes in consultation rates, medication use and work absences due to migraine and tension-type headache (TTH) in Denmark over a 12-year period.
METHODS: Surveys of the general population in 1989 and 2001. Medical doctors conducted all headache diagnostic interviews based on ICDH-I and II. The participation rate was 76% (740) in 1989 and 74% (711) in 2001. Headache status was categorized as pure migraine, pure frequent TTH (frequent episodic or chronic TTH), coexisting migraine and frequent TTH, and healthy subjects (no primary headache or only infrequent TTH).
RESULTS: Headache-related consultation rates (OR = 1.6 (1.1-2.2)), especially specialist consultations (OR = 3.6 (2.3-5.6)), increased for all headache groups. Use of prescription medication because of headache increased moderately (OR = 2.1 (1.1-3.9)) while the use of prophylactic medication was stable (OR = 1.1 (0.3-4.0)). Both headache-related (OR = 1.1 (0.7-1.7)) and overall (OR = 0.9 (0.7-1.2)) absence rates were largely unchanged. Headache-related absence rates were higher for subjects with both headache types (OR = 7.5 (4.3-13.1)) or with pure migraine (OR = 3.6 (2.0-6.6)) than for subjects with frequent TTH alone. Triptans users had higher migraine headache frequency and tended to have higher absence rates than non-users. Overall absence rates were higher for subjects with both headache types (OR = 2.3 (1.3-4.0)) or with frequent TTH (OR = 1.9 (1.4-2.7)) than for healthy subjects. Pure migraine was not associated with higher overall absence rates (OR = 1.0 (0.6-1.6)).
CONCLUSION: Despite an increase in headache consultation rates and in use of prescription medication and triptans, no improvement in work absence rates was observed. Consultations, medication use, and absence rates were highest for individuals with both migraine and frequent TTH.

Entities:  

Mesh:

Year:  2005        PMID: 16331432     DOI: 10.1007/s10654-005-3778-5

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  37 in total

1.  The International Classification of Headache Disorders: 2nd edition.

Authors: 
Journal:  Cephalalgia       Date:  2004       Impact factor: 6.292

2.  The burden of illness associated with headache disorders among young adults in a representative cohort study.

Authors:  Karen E Waldie; Richie Poulton
Journal:  Headache       Date:  2002 Jul-Aug       Impact factor: 5.887

3.  Consulting behaviour in migraine and tension-type headache sufferers: a population survey in Santiago, Chile.

Authors:  P M Lavados; E Tenhamm
Journal:  Cephalalgia       Date:  2001-09       Impact factor: 6.292

4.  Health care utilisation among individuals reporting long-term pain: an epidemiological study based on Danish National Health Surveys.

Authors:  Jørgen Eriksen; Per Sjøgren; Ola Ekholm; Niels K Rasmussen
Journal:  Eur J Pain       Date:  2004-12       Impact factor: 3.931

5.  Clinical characteristics and patterns of medication use of migraneurs in Latin America from 12 cities in 6 countries.

Authors:  Luis E Morillo; Fernando Alarcon; Nayesca Aranaga; Sara Aulet; Evelina Chapman; Lucien Conterno; Edmundo Estevez; Felipe Garcia-Pedroza; Juanita Garrido; Miguel Macias-Islas; Paulo Monzillo; Lilia Nunez; Noel Plascencia; Carlos Rodriguez; Yuri Takeuchi
Journal:  Headache       Date:  2005-02       Impact factor: 5.887

6.  Lost workdays and decreased work effectiveness associated with headache in the workplace.

Authors:  B S Schwartz; W F Stewart; R B Lipton
Journal:  J Occup Environ Med       Date:  1997-04       Impact factor: 2.162

Review 7.  Epidemiology of headache.

Authors:  B K Rasmussen
Journal:  Cephalalgia       Date:  1995-02       Impact factor: 6.292

8.  Patterns of health care utilization for migraine in England and in the United States.

Authors:  R B Lipton; A I Scher; T J Steiner; M E Bigal; K Kolodner; J N Liberman; W F Stewart
Journal:  Neurology       Date:  2003-02-11       Impact factor: 9.910

9.  Attitudes and burden of disease among self-considered migraineurs--a nation-wide population-based survey in Sweden.

Authors:  M Linde; C Dahlöf
Journal:  Cephalalgia       Date:  2004-06       Impact factor: 6.292

10.  Migraine headache: epidemiology and health care utilization.

Authors:  W F Stewart; R B Lipton
Journal:  Cephalalgia       Date:  1993-04       Impact factor: 6.292

View more
  27 in total

Review 1.  Taking the negative view of current migraine treatments: the unmet needs.

Authors:  Peer Tfelt-Hansen; Jes Olesen
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

Review 2.  Aspirin for acute treatment of episodic tension-type headache in adults.

Authors:  Sheena Derry; Philip J Wiffen; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2017-01-13

Review 3.  Burden of tension-type headache.

Authors:  Marc E Lenaerts
Journal:  Curr Pain Headache Rep       Date:  2006-12

Review 4.  Tension-type headache with medication overuse: pathophysiology and clinical implications.

Authors:  Teshamae S Monteith; Michael L Oshinsky
Journal:  Curr Pain Headache Rep       Date:  2009-12

5.  Spinal rehabilitative exercise or manual treatment for the prevention of tension-type headache in adults.

Authors:  Brent Leininger; Gert Brønfort; Mitchell Haas; John Schmitt; Roni L Evans; Morris Levin; Kristine Westrom; Charles H Goldsmith
Journal:  Cochrane Database Syst Rev       Date:  2016-04-07

Review 6.  Paracetamol (acetaminophen) for acute treatment of episodic tension-type headache in adults.

Authors:  Guy Stephens; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-06-16

7.  Tolerability and efficacy of a combination of paracetamol and caffeine in the treatment of tension-type headache: a randomised, double-blind, double-dummy, cross-over study versus placebo and naproxen sodium.

Authors:  Luigi Alberto Pini; Enrico Del Bene; Giorgio Zanchin; Paola Sarchielli; Girolamo Di Trapani; Maria Pia Prudenzano; Giovanni LaPegna; Lidia Savi; Giorgio Di Loreto; Paolo Dionisio; Franco Granella
Journal:  J Headache Pain       Date:  2008-09-25       Impact factor: 7.277

Review 8.  Ketoprofen for episodic tension-type headache in adults.

Authors:  Lucy Veys; Sheena Derry; R Andrew Moore
Journal:  Cochrane Database Syst Rev       Date:  2016-09-22

Review 9.  Impact of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andrée
Journal:  J Headache Pain       Date:  2008-04-17       Impact factor: 7.277

Review 10.  Migraine and structural changes in the brain: a systematic review and meta-analysis.

Authors:  Asma Bashir; Richard B Lipton; Sait Ashina; Messoud Ashina
Journal:  Neurology       Date:  2013-08-28       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.